全球败血症市场 – 行业趋势和 2029 年预测

市场分析和规模

各种传染病病例激增导致败血症患病率不断上升，预计这将推动全球市场的增长。败血症市场在很大程度上受到主要参与者对分子诊断领域技术进步的关注度不断上升以及与其他组织的合作和伙伴关系的影响。由于存在各种增长决定因素，市场正在向前发展，预计在预测期内将出现大幅增长。

• 2021 年全球败血症市场价值为 33 亿美元，预计到 2029 年将达到 68 亿美元，在 2022-2029 年预测期内的复合年增长率为 8.5%。由于细菌性败血症病例增加和 HAI 患病率上升，“细菌”在预测期内占败血症市场中最大的病原体部分。Data Bridge 市场研究团队策划的市场报告包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

市场定义

败血症是一种由免疫系统减弱导致的危险后果，使患者容易受到细菌、病毒、真菌、寄生虫和其他疾病的侵害。这是医院死亡的主要原因之一。当宿主的免疫系统对感染作出反应时，免疫系统会产生化学物质来治疗感染，从而导致败血症。当它进入血液时，它会引发全身炎症。它进一步导致血管渗漏、血栓和血流不畅，使身体的重要器官缺氧和营养。

败血症也被认为是一种三阶段疾病，通常从败血症开始，然后发展为严重败血症，最后发展为败血性休克，这是一种医疗紧急情况。免疫系统较弱的人、年轻人、老年人以及患有糖尿病、艾滋病、癌症等慢性疾病的人患败血症的风险较高。

Sepsis Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

• Growing Burden Of Infectious Diseases

The growing burden of infectious diseases which leads to the rising number of sepsis incidences, is the most significant factor driving the growth for this market. Growing cases of the hospital-acquired infections (HAIs) such as urinary tract infections, pneumonia and sepsis are also expected to accelerate the overall growth of the market.

Growing Investments and Advancements

An increase in funding for sepsis-related research activities combined with the rising investments in extensive research and development activities that include new blood culture approaches for identifying and treating chronic infections are also projected to cushion the growth of the market. Moreover, the technological advances in the field of molecular diagnostics, coupled with surging requirement for quick and accurate results are estimated to generate lucrative opportunities for the market. Various technological advancements have led to the emergence of novel immunological and molecular biomarkers that enable the early detection of sepsis, which will further expand the sepsis market's growth rate in the future.

Furthermore, the expanding healthcare sector along with the increasing penetration of advanced data analytics tools are also expected to fuel market growth. Moreover, the rising awareness among the patients and doctors regarding the chronic diseases and hospital acquired infections also cushions the market’s growth within the forecasted period.

Restraints/Challenges

• High Costs of Diagnosis

On the other hand, cost of molecular diagnostic tests is very high, which is expected to obstruct market growth.

• Dearth of Professionals

Also, the sepsis needs to be diagnosed and treated early with help of skilled healthcare professionals. The shortage of skilled professionals or lack of trained paramedics are projected to challenge the sepsis market in the forecast period of 2022-2029.

This sepsis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sepsis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Sepsis Market

The sepsis market was largely industry impacted by the outbreak of COVID-19. The sepsis symptoms such as multiorgan damage emerged in approximately 2- 5% of COVID patients, that too after 8-10 days of admission. To deal with the dilemma, the Biomedical Advanced Research and Development Authority collaborated with Beckman Coulter to build a digital algorithm to detect sepsis in COVID-19 patients. The outbreak of coronavirus and the emergence of sepsis cases among covid-19 patients boosted the demand for quick diagnosis, resulting in a faster adoption of devices, reagents, and test kits for sepsis detection. Moreover, the geriatric population are vulnerable to complications such as acute respiratory distress syndrome (ARDS) that is caused by pneumonia and raises the risk of sepsis.

Recent Developments

• In June 2021, BioMérieux, a global pioneer in in vitro diagnostics, and Special Diagnostics, a business that brings new in vitro diagnostic methods to clinical microbiology, have inked a distribution agreement for a specific reveal fast AST system in Europe. The REVEAL Rapid AST system, developed by Specific Diagnostics and based on its patented metabolomic signature technology, provides actionable results for bloodstream infections (in an average of 5 hours* directly from positive blood culture), allowing either timely de-escalation to a more focused, more appropriate, and lower-cost therapy, or life-saving rapid escalation to a more effective drug when a multidrug-resistant (MDR) infection is present.

Global Sepsis Market Scope

败血症市场根据类型、产品、技术、检测类型、病原体、分销渠道、最终用户和应用进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

类型

• 诊断
• 疗法

根据类型，败血症市场分为诊断和治疗。

产品

• 试剂
• 测定
• 仪器
• 软件

根据产品，败血症市场分为试剂、检测、仪器和软件。

技术

• 微生物学
• 聚合酶链反应
• 测序
• 生物标志物

根据技术，败血症市场分为微生物学、PCR、测序和生物标志物。

测试类型

• 实验室
• 波克

根据测试类型，败血症市场分为实验室和 POC。

病原

• 细菌
• 病毒性的
• 真菌

根据病原体，败血症市场分为细菌性、病毒性和真菌性。由于细菌性败血症病例增加和医院感染患病率上升，预测期内细菌性败血症占据最大市场份额。

分销渠道

• 医院药房
• 零售药店
• 网上药店

根据分销渠道，败血症市场分为医院药房、零售药店和网上药店。

最终用户

• 医院
• 病理
• 参考实验室

根据最终用户，败血症市场分为医院、病理学和参考实验室。

应用

• 脓毒症
• 严重脓毒症
• 感染性休克

根据应用，败血症市场分为败血症、严重败血症和感染性休克。

败血症市场区域分析/见解

对败血症市场进行了分析，并按国家、类型、产品、技术、测试类型、病原体、分销渠道、最终用户和应用提供了市场规模见解和趋势。

败血症市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

北美在败血症市场占据主导地位，因为该地区人均医疗支出增加、对更好医疗设施的需求增加、越来越多地采用新的和先进的诊断技术以及癌症、糖尿病等导致败血症的慢性疾病发病率增加。

由于老年人口比例高、印度、中国和澳大利亚等国家癌症和糖尿病患病率不断上升以及该地区医疗保健基础设施不断发展，预计亚太地区将在 2022 年至 2029 年的预测期内出现显著增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

败血症市场还为您提供每个国家/地区资本设备医疗支出增长、败血症市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗监管情景的变化及其对败血症市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。

竞争格局和败血症市场份额分析

败血症市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对败血症市场的关注有关。

败血症市场的一些主要参与者包括 bioMérieux（法国）、BD（美国）、丹纳赫（美国）、Biosystems Inc.（美国）、Luminex Corporation（美国）、F. Hoffmann-La Roche Ltd.（瑞士）、Thermo Fisher Scientific Inc.（美国）、Bruker（美国）、雅培（美国）、Immunexpress Inc.（美国）、Axis-Shield Diagnostics Ltd.（英国）、Quidel Corporation（美国）、西门子（德国）、EKF Diagnostics（英国）、Seegene Inc.（韩国）、Boditech Med Inc.（韩国）和 Alifax Srl Italy（意大利）等。

SKU-52531